Image pharmaphorum Editor Market Access CSL opens a new R&D facility in Waltham, Massachusetts On March 27th, global biopharma company CSL opened a new R&D facility in Waltham, Massachusetts. Market Access What the HRT is happening with menopause care in the UK? Menopause is a natural process that occurs as women age and marks the end of their reproductive years. News Securing Market Access to Medicines for England, Ireland, Sc... The PM Society Market Access Interest Group (MAIG) is gearing up to host its next in-person meeting on Tuesday, May 23rd, at the prestigious Royal Society of Medicine in London. Sales & Marketing Sponsored 12 Questions with Gareth Phillips Gareth Phillips was recently appointed CEO of healthcare market research agency, Research Partnership. Load more results
Market Access CSL opens a new R&D facility in Waltham, Massachusetts On March 27th, global biopharma company CSL opened a new R&D facility in Waltham, Massachusetts.
Market Access What the HRT is happening with menopause care in the UK? Menopause is a natural process that occurs as women age and marks the end of their reproductive years.
News Securing Market Access to Medicines for England, Ireland, Sc... The PM Society Market Access Interest Group (MAIG) is gearing up to host its next in-person meeting on Tuesday, May 23rd, at the prestigious Royal Society of Medicine in London.
Sales & Marketing Sponsored 12 Questions with Gareth Phillips Gareth Phillips was recently appointed CEO of healthcare market research agency, Research Partnership.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
